Stefanie Hayoz

3.5k total citations
98 papers, 1.6k citations indexed

About

Stefanie Hayoz is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stefanie Hayoz has authored 98 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 28 papers in Surgery and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stefanie Hayoz's work include Prostate Cancer Treatment and Research (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Stefanie Hayoz is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Stefanie Hayoz collaborates with scholars based in Switzerland, Germany and Italy. Stefanie Hayoz's co-authors include Anne Peutzfeldt, Simon Flury, Jürg Hüsler, Adrian Lussi, Sigrid Beer‐Borst, Corinna Krause, Kathrin Sommerhalder, Thomas Abel, Richard Cathomas and Karin Ribi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgery.

In The Last Decade

Stefanie Hayoz

91 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie Hayoz Switzerland 20 506 403 335 264 223 98 1.6k
Giuseppe Colella Italy 26 804 1.6× 813 2.0× 382 1.1× 110 0.4× 42 0.2× 152 2.4k
Daniel D. Lydiatt United States 23 362 0.7× 643 1.6× 220 0.7× 45 0.2× 139 0.6× 68 1.5k
Richard T. Kao United States 29 379 0.7× 283 0.7× 89 0.3× 203 0.8× 101 0.5× 76 2.6k
Jonathan Rees United Kingdom 19 316 0.6× 426 1.1× 250 0.7× 68 0.3× 96 0.4× 67 1.2k
Athanasios I. Zavras United States 20 632 1.2× 186 0.5× 120 0.4× 55 0.2× 67 0.3× 53 1.7k
Jerry E. Bouquot United States 29 452 0.9× 474 1.2× 147 0.4× 670 2.5× 74 0.3× 85 2.9k
Alessandro Antonelli Italy 24 233 0.5× 316 0.8× 99 0.3× 120 0.5× 75 0.3× 65 1.5k
Martin Batstone Australia 22 262 0.5× 822 2.0× 333 1.0× 44 0.2× 70 0.3× 94 1.7k
Sérgio Ajzen Brazil 23 88 0.2× 424 1.1× 342 1.0× 49 0.2× 115 0.5× 92 1.5k
Young Ho Kim South Korea 23 330 0.7× 251 0.6× 150 0.4× 46 0.2× 31 0.1× 52 1.2k

Countries citing papers authored by Stefanie Hayoz

Since Specialization
Citations

This map shows the geographic impact of Stefanie Hayoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Hayoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Hayoz more than expected).

Fields of papers citing papers by Stefanie Hayoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Hayoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Hayoz. The network helps show where Stefanie Hayoz may publish in the future.

Co-authorship network of co-authors of Stefanie Hayoz

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Hayoz. A scholar is included among the top collaborators of Stefanie Hayoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Hayoz. Stefanie Hayoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özdemir, Berna C., Ruben Bill, Alper Okyar, et al.. (2025). Chrono-immunotherapy as a low-hanging fruit for cancer treatment? A call for pragmatic randomized clinical trials. Journal for ImmunoTherapy of Cancer. 13(3). e010644–e010644. 1 indexed citations
2.
Zhao, Shuang, Hyunnam Ryu, J. Proudfoot, et al.. (2025). Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials.. Journal of Clinical Oncology. 43(5_suppl). 308–308. 2 indexed citations
3.
4.
Klose, Martina, Simon Haefliger, Manuela Rabaglio, et al.. (2025). 35P TLD-1 – A novel liposomal doxorubicin formulation, in patients with advanced solid tumors: Final results of a multicenter, open-label, cross-over phase I study (SAKK 65/16). ESMO Open. 10. 104193–104193. 1 indexed citations
5.
Güller, Ulrich, Stefanie Hayoz, Daniel Horber, et al.. (2024). 512O Adjuvant aspirin treatment in PIK3CA mutated colon cancer patients: The phase III, prospective-randomized placebo-controlled multicenter SAKK 41/13 trial. Annals of Oncology. 35. S432–S432. 5 indexed citations
6.
Hayoz, Stefanie, et al.. (2024). Deep inspirational breast hold (DIBH) for right breast irradiation: Improved sparing of liver and lung tissue. Clinical and Translational Radiation Oncology. 45. 100731–100731. 2 indexed citations
7.
Colombo, Ilaria, Simon Haefliger, Manuela Rabaglio, et al.. (2024). TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16). European Journal of Cancer. 201. 113588–113588. 10 indexed citations
8.
Johnson, Kristen, Stefanie Hayoz, Alfonso Mora, et al.. (2024). Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison. Supportive Care in Cancer. 32(8). 554–554. 3 indexed citations
9.
Bubendorf, Lukas, et al.. (2024). Efficacy and tolerability of bacillus Calmette-Guérin strain Russia for the treatment of non-muscle-invasive bladder cancer. Canadian Urological Association Journal. 18(7). E233–E239. 1 indexed citations
10.
Hayoz, Stefanie, Benjamin Kasenda, Christoph Kopp, et al.. (2023). Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK). BMJ Open. 13(4). e068490–e068490. 2 indexed citations
11.
Gillessen, Silke, Giuseppe Procopio, Stefanie Hayoz, et al.. (2023). Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16). Journal of Clinical Oncology. 41(20). 3608–3615. 2 indexed citations
12.
13.
Joerger, Markus, Yannis Metaxas, Khalil Zaman, et al.. (2022). Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA). Cancers. 14(9). 2191–2191. 3 indexed citations
14.
Panje, Cédric, Stefanie Hayoz, Wolfgang Eisterer, et al.. (2022). Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial. European Journal of Cancer. 177. 186–193. 2 indexed citations
15.
Ceriani, Luca, Lisa Milan, Luciano Cascione, et al.. (2021). Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R‐CHOP14: A SAKK 38/07 trial post‐hoc analysis. Hematological Oncology. 40(1). 12–22. 20 indexed citations
16.
Moccia, Alden A., Christian Taverna, Sämi Schär, et al.. (2020). Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial. Blood Advances. 4(23). 5951–5957. 17 indexed citations
17.
18.
Hess, Dagmar, Ilaria Colombo, Simon Haefliger, et al.. (2020). 575P TLD-1, a novel liposomal doxorubicin, in patients (pts) with advanced solid tumours: Dose escalation part of a multicenter open-label phase I trial (SAKK 65/16). Annals of Oncology. 31. S490–S490. 2 indexed citations
19.
Ceriani, Luca, Giuseppe Gritti, Luciano Cascione, et al.. (2020). SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model. Blood Advances. 4(6). 1082–1092. 57 indexed citations
20.
Beer‐Borst, Sigrid, Xhyljeta Luta, Stefanie Hayoz, et al.. (2018). Study design and baseline characteristics of a combined educational and environmental intervention trial to lower sodium intake in Swiss employees. BMC Public Health. 18(1). 421–421. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppe Colella Breakdown of academic impact, for papers by Daniel D. Lydiatt Breakdown of academic impact, for papers by Richard T. Kao Breakdown of academic impact, for papers by Jonathan Rees Breakdown of academic impact, for papers by Athanasios I. Zavras Breakdown of academic impact, for papers by Jerry E. Bouquot Breakdown of academic impact, for papers by Alessandro Antonelli Breakdown of academic impact, for papers by Martin Batstone Breakdown of academic impact, for papers by Sérgio Ajzen Breakdown of academic impact, for papers by Young Ho Kim
Rankless by CCL
2026